Clene
CLNN4.7205.41% ( -0.270 )
Clene (CLNN)
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) t...
- Open
- 4.870
- High
- 5.040
- Low
- 4.630
- Prev. Close
- 4.990
- Volume
- 140.75K
- Turnover
- 677.18K
- Avg Price
- 4.811
- Bid/Ask Ratio
- --
- Amplitude
- 8.22%
- 52wk High
- 13.500
- Volume Ratio
- 2.30
- Turnover Ratio
- 1.59%
Clene Analyst Rating
View MoreForecast & Rating
May 27, 2026Price forecast
$32.20582.20%
Forecast & RatingStrong buy
5analysts
- Strong buy80.00%
- Buy20.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 22 hours ago
Clene to present at Canaccord Growth Conference, host investor meetings
- Market Beat · Jul 17 at 05:29 AM
Clene Inc. (NASDAQ:CLNN) Receives Consensus Rating of "Moderate Buy" from Analysts
- Market Beat · Jul 11 at 01:02 PM
Top Nanotechnology Stocks Worth Watching - July 11th
- TradingView · May 22 at 03:43 PM
Clene Extends 2025 Convertible Notes to 2027, Defers $150,000 Monthly Payments
- Tip Ranks · May 15 at 07:40 AM
Clene (CLNN) Gets a Buy from JonesTrading
- Tip Ranks · May 14 at 07:32 AM
Clene Extends Debt Maturities and Strengthens Cash Runway
